Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Awareness of adverse effects of angiotensin inhibiting medications in female adolescents treated for kidney disease and/or hypertension

  • At: 2013 FIP Congress in Dublin (Ireland)
  • Type: Poster
  • By: VAILLANCOURT, Régis (Children's Hospital of Eastern Ontario, Pharmacy, Ottawa, Canada)
  • Co-author(s): Prehogan, I.P. (Children's Hospital of Eastern Ontario, Ottawa, Canada)
    Tsampalieros, A.T. (Children's Hospital of Eastern Ontario, Ottawa, Canada)
    Boulanger, C. (Children's Hospital of Eastern Ontario, Ottawa, Canada)
    Chretien, A.C. (Children's Hospital of Eastern Ontario, Ottawa, Canada)
    Tam, P.T. (Children's Hospital of Eastern Ontario, Ottawa, Canada)
    Feber, Janus (Children's Hospital of Eastern Ontario, Ottawa, Canada)
  • Abstract:


    Background

    : Angiotensin converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) are frequently used for nephroprotection and blood pressure therapy. One of the known adverse effects is the risk of fetal deformities if taken in pregnancy.


    Aim

    : The objective of the study was to assess the awareness of the teratogenic adverse

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses